Bibliometric analysis of research hotspots and trends on Parkinson's disease with excessive daytime sleepiness based on Web of Science database

Published on Aug. 03, 2026Total Views: 41 times Total Downloads: 7 times Download Mobile

Author: XIE Zhongxuan ¹ XU Zitong ² JIN Wei ² Jesús M.Cortés ³  LI Lihong ²

Affiliation: 1.The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310000, China 2.Department of Acupuncture and Moxibustion, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China 3.Department of Cell Biology and Histology, University of the Basque Country, Leioa 48940, Spain

Keywords: Parkinson's disease Excessive daytime sleepiness CiteSpace Bibliometrics Depression Dopamine receptor agonists Pathogenesis

DOI: 10.12173/j.issn.1004-4337.202509047

Reference: Xie ZX, Xu ZT, Jin W, et al. Bibliometric analysis of research hotspots and trends on Parkinson's disease with excessive daytime sleepiness based on Web of Science database[J]. Journal of Mathematical Medicine, 2026, 39(7): 497-505. DOI: 10.12173/j.issn.1004-4337.202509047.[Article in Chinese]  Copied

Abstract
Full-text
References

Abstract

Objective To conduct a bibliometric and visualization analysis of the relevant literature on Parkinson's disease with excessive daytime sleepiness to reveal the research hotspots and development trends in this field.

Methods The relevant literature on Parkinson's disease with excessive daytime sleepiness published in Web of Science Core Collection database was retrieved from its establishment to September 21, 2025. The CiteSpace 6.1.6R software was used to conduct a visual analysis of the number of publications, authors, institutions, countries/regions, keywords, and cited literature.

Results A total of 746 articles were included. The number of publications was the highest in 2022 (n=53), and the number of publications has shown a downward trend since then. Chaudhuri KR had the highest number of publications (n=16) and citation frequency (n=299), and King's Coll London had the highest number of publications (n=27). The United States had the highest number of publications (n=176). The results of keyword co-occurrence and literature co-citation analysis showed that dopamine receptor agonists, depression, deep brain stimulation, quality of life, and disease mechanism are the current research hotspots.

Conclusion Parkinson's disease with excessive daytime sleepiness is closely related to the adverse reactions of dopamine receptor agonists. The pathogenesis, depression, and dopamine receptor agonists may be the research hotspots in the future. Future research should focus on the epidemiological characteristics of psychotropic drugs in Parkinson's disease patients and their association with excessive daytime sleepiness, in order to provide a basis for safe clinical medication.

Full-text

Please download the PDF version to read the full text: download

References

1. de LauLM, BretelerMM. Epidemiology of Parkinson's disease[J]. Lancet Neurol, 2006, 5(6): 525-535. DOI: 10.1016/s1474-4422(06)70471-9.

2. ZhangPL, ChenY, ZhangCH, et al. Genetics of Parkinson's disease and related disorders[J]. J Med Genet, 2018, 55(2): 73-80. DOI: 10.1136/jmedgenet-2017-105047.

3. HobsonDE, LangAE, MartinWR, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group[J]. JAMA, 2002, 287(4): 455-463. DOI: 10.1001/jama.287.4.455.

4. TávoraDG, de BruinVM, Lopes GamaR, et al. The nature of excessive sleepiness and sudden sleep onset in Parkinson׳s disease[J]. Sleep Sci, 2014, 7(1): 13-18. DOI: 10.1016/j.slsci.2014.07.020.

5. DodetP, HouotM, Leu-SemenescuS, et al. Sleep disorders in Parkinson's disease, an early and multiple problem[J]. NPJ Parkinsons Dis, 2024, 10(1): 46. DOI: 10.1038/s41531-024-00642-0.

6. GandhiKD, MansukhaniMP, SilberMH, et al. Excessive daytime sleepiness: a clinical review[J]. Mayo Clin Proc, 2021, 96(5): 1288-1301. DOI: 10.1016/j.mayocp.2020.08.033.

7. DengP, WangS, SunX, et al. Global trends in research of gouty arthritis over past decade: a bibliometric analysis[J]. Front Immunol, 2022, 13: 910400. DOI: 10.3389/fimmu.2022.910400.

8. GuanL, LiuY, WuB, et al. Research hotspots and trends in visceral pain research: a global comprehensive bibliometric analysis[J]. Front Mol Neurosci, 2022, 15: 1022463. DOI:10.3389/fnmol.2022.1022463.

9. ChenC. Searching for intellectual turning points: progressive knowledge domain visualization[J]. Proc Natl Acad Sci U S A, 2004, 101Suppl 1(Suppl 1): 5303-5310. DOI: 10.1073/pnas.0307513100.

10. LiM, JiangZ, WenR, et al. A bibliometric analysis of the application of imaging in sleep in neurodegenerative disease[J]. Front Aging Neurosci, 2023, 15: 1078807. DOI: 10.3389/fnagi.2023.1078807.

11. GaoM, GaoD, SunH, et al. Trends in research related to premenstrual syndrome and premenstrual dysphoric disorder from 1945 to 2018: a bibliometric analysis[J]. Front Public Health, 2021, 9: 596128. DOI: 10.3389/fpubh.2021.596128.

12. AvinC, LotkerZ, PelegD, et al. Elites in social networks: an axiomatic approach to power balance and Price's square root law[J]. PLoS One, 2018, 13(10): e0205820. DOI: 10.1371/journal.pone.0205820.

13. CheS, KamphuisP, ZhangS, et al. A visualization analysis of crisis and risk communication research using CiteSpace[J]. Int J Environ Res Public Health, 2022, 19(5): 2923. DOI: 10.3390/ijerph19052923.

14. LiuC, YuR, ZhangJ, et al. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: a machine learning bibliometric analysis from 2012 to 2021[J]. Front Immunol, 2022, 13: 972079. DOI: 10.3389/fimmu.2022.972079.

15. PengS, XiaY, WangY, et al. Research hotspots and trend analysis of abdominal pain in inflammatory bowel disease: a bibliometric and visualized analysis[J]. Front Pharmacol, 2023, 14: 1220418. DOI: 10.3389/fphar.2023.1220418.

16. ShenY, HuangJY, LiJ, et al. Excessive daytime sleepiness in Parkinson's disease: clinical implications and management[J]. Chin Med J (Engl), 2018, 131(8): 974-981. DOI: 10.4103/0366-6999.229889.

17. FengF, CaiY, HouY, et al. Excessive daytime sleepiness in Parkinson's disease: a systematic review and meta-analysis[J]. Parkinsonism Relat Disord, 2021, 85: 133-140. DOI: 10.1016/j.parkreldis.2021.02.016.

18. XiangYQ, XuQ, SunQY, et al. Clinical features and correlates of excessive daytime sleepiness in Parkinson's disease[J]. Front Neurol, 2019, 10: 121. DOI: 10.3389/fneur.2019.00121.

19. SuzukiK, OkumaY, UchiyamaT, et al. Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study[J]. J Neurol Neurosurg Psychiatry, 2017, 88(11): 953-959. DOI:10.1136/jnnp-2017-316136.

20. ChahineLM, AmaraAW, VidenovicA. A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015[J]. Sleep Med Rev, 2017, 35: 33-50. DOI: 10.1016/j.smrv.2016.08.001.

21. ChaudhuriKR, PalS, Brefel-CourbonC. 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?[J]. Drug Saf, 2002, 25(7): 473-483. DOI: 10.2165/00002018-200225070-00001.

22. KnieB, MitraMT, LogishettyK, et al. Excessive daytime sleepiness in patients with Parkinson's disease[J]. CNS Drugs, 2011, 25(3): 203-212. DOI: 10.2165/11539720-000000000-00000.

23. TallP, QamarMA, RosenzweigI, et al. The park sleep subtype in Parkinson's disease: from concept to clinic[J]. Expert Opin Pharmacother, 2023, 24(15): 1725-1736. DOI: 10.1080/14656566.2023.2242786.

24. Falup-PecurariuC, MunteanML, UngureanuL, et al. Pharmacological and non-pharmacological management of sleep disturbances in Parkinson's disease: if when and how[J]. Expert Opin Pharmacother, 2024, 25(16): 2135-2149. DOI: 10.1080/14656566.2024.2422004.

25. WoodLD. Clinical review and treatment of select adverse effects of dopamine receptor agonists in Parkinson's disease[J]. Drugs Aging, 2010, 27(4): 295-310. DOI: 10.2165/11318330-000000000-00000.

26. AmaraAW, ChahineLM, Caspell-GarciaC, et al. Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2017, 88(8): 653-662. DOI: 10.1136/jnnp-2016-315023.

27. WangH, ZhaoY, SchragA. Development of anxiety in early Parkinson's disease: a clinical and biomarker study[J]. Eur J Neurol, 2023, 30(9): 2661-2668. DOI: 10.1111/ene.15890.

28. RuttenS, VriendC, van der WerfYD, et al. The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease[J]. Parkinsonism Relat Disord, 2017, 39: 31-36. DOI:10.1016/j.parkreldis.2017.01.015.

29. ChungS, BohnenNI, AlbinRL, et al. Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities[J]. J Clin Sleep Med, 2013, 9(11): 1131-1137. DOI: 10.5664/jcsm.3150.

30. ChaudhuriKR, HealyDG, SchapiraAH, et al. Non-motor symptoms of Parkinson's disease: diagnosis and management[J]. Lancet Neurol, 2006, 5(3): 235-245. DOI: 10.1016/s1474-4422(06)70373-8.

31. RemyP, DoderM, LeesA, et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system[J]. Brain, 2005, 128(Pt 6): 1314-1322. DOI:10.1093/brain/awh445.

32. IranzoA. Parkinson's disease and sleepiness[J]. Sleep Med Clin, 2006, 1(1): 1-18. DOI: 10.1016/j.jsmc.2015.10.011.

33. BrowningM, CowenPJ, GalalU, et al. Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK[J]. Lancet Psychiatry, 2025, 12(8): 579-589. DOI: 10.1016/s2215-0366(25)00194-4.

34. HoriH, KunugiH. Dopamine agonist-responsive depression[J]. Psychogeriatrics, 2013, 13(3): 189-195. DOI: 10.1111/psyg.12014.

35. HyacintheC, BarraudQ, TisonF, et al. D1 receptor agonist improves sleep-wake parameters in experimental parkinsonism[J]. Neurobiol Dis, 2014, 63: 20-24. DOI: 10.1016/j.nbd.2013.10.029.

36. KaynakD, KiziltanG, KaynakH, et al. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment[J]. Eur J Neurol, 2005, 12(3): 199-207. DOI: 10.1111/j.1468-1331.2004.00971.x.

37. OndoWG, Dat VuongK, KhanH, et al. Daytime sleepiness and other sleep disorders in Parkinson's disease[J]. Neurology, 2001, 57(8): 1392-1396. DOI: 10.1212/wnl.57.8.1392.

38. AndoR, ChoudhuryME, YamanishiY, et al. Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease[J]. J Pharmacol Sci, 2018, 136(4): 266-271. DOI: 10.1016/j.jphs.2018.03.005.